Literature DB >> 10082835

Corticotropin-releasing hormone expression is the major target for glucocorticoid feedback-control at the hypothalamic level.

O Kretz1, H M Reichardt, G Schütz, R Bock.   

Abstract

Glucocorticoid production is controlled via the hypothalamo-pituitary-adrenal (HPA) axis by a negative feedback mechanism involving the glucocorticoid receptor (GR). A major site of regulation is the hypothalamus, where the GR is thought to repress the expression of genes such as corticotropin-releasing hormone (CRH) and arginine-vasopressin (AVP). To define the role of the GR in this feedback loop in more detail, the content of CRH, AVP and neurophysin in the median eminence of mice carrying a targeted disruption of the GR gene was studied using immunohistochemistry. GR-deficient mice were found to contain five times more CRH in the median eminence than wild-type littermates. In contrast, no significant change in the content of AVP was observed in the outer layer of the median eminence and neurophysin was also only moderately increased. Our studies suggest that, at the hypothalamic level, CRH synthesis is the major target for feedback control by the GR and that transcriptional control of AVP and neurophysin plays only a supportive role in this process. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082835     DOI: 10.1016/s0006-8993(98)01277-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

Review 1.  Molecular mechanisms of glucocorticoid action: what is important?

Authors:  R Newton
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

Review 2.  Regulation of Adult Neurogenesis and Plasticity by (Early) Stress, Glucocorticoids, and Inflammation.

Authors:  Paul J Lucassen; Charlotte A Oomen; Eva F G Naninck; Carlos P Fitzsimons; Anne-Marie van Dam; Boldizsár Czeh; Aniko Korosi
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-09-01       Impact factor: 10.005

Review 3.  Glucocorticoids and the ageing hippocampus.

Authors:  C Hibberd; J L Yau; J R Seckl
Journal:  J Anat       Date:  2000-11       Impact factor: 2.610

Review 4.  Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.

Authors:  Marian L Logrip; George F Koob; Eric P Zorrilla
Journal:  CNS Drugs       Date:  2011-04       Impact factor: 5.749

5.  Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock.

Authors:  H M Reichardt; T Umland; A Bauer; O Kretz; G Schütz
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

6.  Bacterial lipopolysaccharide-induced coordinate downregulation of arginine vasopressin receptor V3 and corticotropin-releasing factor receptor 1 messenger ribonucleic acids in the anterior pituitary of endotoxemic steers.

Authors:  Isam M Qahwash; Carolyn A Cassar; Roy P Radcliff; George W Smith
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

Review 7.  Hypothalamic-pituitary-adrenal axis dysregulation and behavioral analysis of mouse mutants with altered glucocorticoid or mineralocorticoid receptor function.

Authors:  Benedict J Kolber; Lindsay Wieczorek; Louis J Muglia
Journal:  Stress       Date:  2008-09       Impact factor: 3.493

8.  Regulation of hypothalamic corticotropin-releasing hormone transcription by elevated glucocorticoids.

Authors:  Andrew N Evans; Ying Liu; Robert Macgregor; Victoria Huang; Greti Aguilera
Journal:  Mol Endocrinol       Date:  2013-09-24

Review 9.  Neuropeptide and steroid hormone mediators of neuroendocrine regulation.

Authors:  A L Heck; C C Crestani; A Fernández-Guasti; D O Larco; A Mayerhofer; C E Roselli
Journal:  J Neuroendocrinol       Date:  2018-08-07       Impact factor: 3.627

10.  Impact of recurring intermediate insulin-induced hypoglycemia on hypothalamic paraventricular corticotropin-releasing hormone, oxytocin, vasopressin and glucokinase gene profiles: role of type II glucocorticoid receptors.

Authors:  Karen P Briski; Ajay Y Kale; Kamlesh V Vavaiya
Journal:  Exp Brain Res       Date:  2009-05-06       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.